DEXAMPEX Drug Patent Profile
✉ Email this page to a colleague
When do Dexampex patents expire, and what generic alternatives are available?
Dexampex is a drug marketed by Teva and is included in two NDAs.
The generic ingredient in DEXAMPEX is dextroamphetamine sulfate. There are eighteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dexampex
A generic version of DEXAMPEX was approved as dextroamphetamine sulfate by BARR on January 31st, 2001.
Summary for DEXAMPEX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 22 |
Patent Applications: | 5,215 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DEXAMPEX at DailyMed |
US Patents and Regulatory Information for DEXAMPEX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | DEXAMPEX | dextroamphetamine sulfate | CAPSULE;ORAL | 085355-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | DEXAMPEX | dextroamphetamine sulfate | TABLET;ORAL | 083735-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Teva | DEXAMPEX | dextroamphetamine sulfate | TABLET;ORAL | 083735-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |